Clinical Trial Detail

NCT ID NCT01959672
Title Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Nebraska
Indications

pancreatic adenocarcinoma

Therapies

Nelfinavir

Oregovomab

Fluorouracil + Leucovorin

Gemcitabine

Age Groups: adult

No variant requirements are available.